Pharmaceuticals Global On demand · 24-48h

Global Color Prestained Protein Standard Market Strategic Research Report

Global Color Prestained Protein Standard Market Strategic Re…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Color Prestained Protein Standard Market
$6822025
5.5%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Single Color, Double Color, Three Colors and Above

By Application: Electrophoresis, Western Blotting, Protein Purification

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Thermo Fisher Scientific, Li-Cor, Genscript, ACT Gene, NCM Biotech, Cell Signaling Technology, Gene Company Limited, Bioesn, Yeasen, X-biotech, NoninBio, Biosharp, Abbkine, U-MeBiotech, Expand Biotech, ACROBiosystems, New England Biolabs, Proteintech, FUJIFILM Wako, SMOBIO Technology, Bioneer, BestEnzymes Biotech, BioDynamics Laboratory

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 161 pages
Market size 2025
$682
Million USD
Forecast CAGR
5.5%
2025-2032
Forecast 2032
$992.1
Projected
リージョン
5
Asia Pacific · Latin America · MEA · Europe · North America

概観

Scope of the Report

The global Color Prestained Protein Standard market size is predicted to grow from US$ 682 million in 2025 to US$ 985 million in 2032; it is expected to grow at a CAGR of 5.5% from 2026 to 2032.

In 2024, the global production of color prestained protein molecular weight standard was 7.15 million vials, with an average price of US$87 per vial.

A Color Prestained Protein Standard is a mixture of proteins of known molecular weights that are pre-labeled with colored dyes. It is used in protein electrophoresis, such as SDS-PAGE (sodium dodecyl sulfate-polyacrylamide gel electrophoresis), to estimate the molecular weights of proteins in a sample and monitor the electrophoresis process in real time.

The upstream supply chain for color-labeled pre-stained protein molecular weight standards mainly includes high-purity protein raw material suppliers, dye and buffer manufacturers, and packaging consumable manufacturers. Representative companies include Merck (Sigma-Aldrich), Thermo Fisher, Cytiva, GenScript, and Takara Bio. Downstream customers are primarily research institutions, university laboratories, biopharmaceutical companies, and CRO service providers, such as Pfizer, Roche, BeiGene, Thermo Fisher Scientific, and the Chinese Academy of Sciences' system laboratories. They extensively use this standard in protein expression, purification validation, and molecular biology research to ensure the accuracy and reproducibility of experimental results.

The development trends of this product are mainly reflected in improved resolution, standardized labeling colors, widespread adoption of pre-mixed ready-to-use formulations, and enhanced compatibility with digital detection. Driving factors include continued growth in global biomedical R&D investment, expanded production scale of proteomics and recombinant proteins, widespread adoption of automated electrophoresis systems, and increased requirements for research reproducibility. Obstacles include the high price of high-end molecular marker reagents, the significant temperature-dependent stability of proteins, and insufficient market education regarding the demand for color standards in some regions.

An annual production line can produce approximately 300,000 to 500,000 standard samples. Standardized brand companies generally have higher gross profit margins, ranging from 45% to 55%, with some high-end ready-to-use products reaching 60%.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Color Prestained Protein Standard market?

What factors are driving Color Prestained Protein Standard market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Color Prestained Protein Standard market opportunities vary by end market size?

How does Color Prestained Protein Standard break out by Type, by Application?

This report presents a comprehensive overview of the global Color Prestained Protein Standard market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Single Color
  • Double Color
  • Three Colors and Above

Segment by Molecular Weight Range

  • Below 10 kDa
  • 10–200 kDa
  • Above 200 kDa

Segment by Number of Bands

  • Less than 8
  • More than 10

Segment by Application

  • Electrophoresis
  • Western Blotting
  • Protein Purification

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Color Prestained Protein Standard market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Electrophoresis, Western Blotting, Protein Purification evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Color Prestained Protein Standard Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 5.5%
Regional growth momentum
Market share by segment
Key metrics
Base value
$682
2025
Forecast
$992.1
2032
CAGR
5.5%
2025–2032
リージョン
5
global
Key companies
Thermo Fisher ScientificLi-CorGenscriptACT GeneNCM BiotechCell Signaling TechnologyGene Company LimitedBioesn
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Single ColorDouble ColorThree Colors and Above
By Application
ElectrophoresisWestern BlottingProtein Purification

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Single Color
  • 3.1.3 Double Color
  • 3.1.4 Three Colors and Above
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Electrophoresis
  • 4.1.3 Western Blotting
  • 4.1.4 Protein Purification
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Thermo Fisher Scientific
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Li-Cor
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Genscript
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 ACT Gene
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 NCM Biotech
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Cell Signaling Technology
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Gene Company Limited
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Bioesn
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Yeasen
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 X-biotech
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 NoninBio
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Biosharp
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Abbkine
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 U-MeBiotech
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Expand Biotech
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 ACROBiosystems
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 New England Biolabs
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Proteintech
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 FUJIFILM Wako
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 SMOBIO Technology
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 Bioneer
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
  • 8.22 BestEnzymes Biotech
  • 8.22.1 Company Overview
  • 8.22.2 Key Products & Segments
  • 8.22.3 Financial Performance (2023–2025)
  • 8.22.4 Business Strategy
  • 8.22.5 SWOT Analysis
  • 8.22.6 Strategic Implications (2026–2032)
  • 8.23 BioDynamics Laboratory
  • 8.23.1 Company Overview
  • 8.23.2 Key Products & Segments
  • 8.23.3 Financial Performance (2023–2025)
  • 8.23.4 Business Strategy
  • 8.23.5 SWOT Analysis
  • 8.23.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Color Prestained Protein Standard market size?
The global Color Prestained Protein Standard market is estimated at US$ 682 million in 2025 (base year) and is projected to reach US$ 985 million by 2032.
What growth rate is expected for the Color Prestained Protein Standard market through 2032?
The market is expected to grow at a CAGR of 5.5% from 2026 to 2032, expanding from US$ 682 million in 2025 to US$ 985 million in 2032, roughly 1.4 times its base-year value.
How is Color Prestained Protein Standard defined?
In 2024, the global production of color prestained protein molecular weight standard was 7.15 million vials, with an average price of US$87 per vial.
How is the Color Prestained Protein Standard market segmented by type?
By type, the market is segmented into Single Color, Double Color and Three Colors and Above.
What are the key applications of Color Prestained Protein Standard?
Key applications covered include Electrophoresis, Western Blotting and Protein Purification.
Which companies are profiled in the Color Prestained Protein Standard market report?
Key players profiled include Thermo Fisher Scientific, Li-Cor, Genscript, ACT Gene, NCM Biotech, Cell Signaling Technology, Gene Company Limited and Bioesn, among 23 companies covered in total.
What geographies does the Color Prestained Protein Standard market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Color Prestained Protein Standard?
Driving factors include continued growth in global biomedical R&D investment, expanded production scale of proteomics and recombinant proteins, widespread adoption of automated electrophoresis systems, and increased requirements for research reproducibility.
Who should buy the Color Prestained Protein Standard market report?
The report is intended for manufacturers and solution providers, distributors and end users in Electrophoresis, Western Blotting and Protein Purification, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Color Prestained Protein Standard market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.